Autoimmune disease is a condition in which the body’s immune system mistakes its own healthy tissues as foreign and attacks them instead of defending. It could be within the body of the individual or ...

Researchers at the University of Louisville were part of a group that discovered an insidious new autoimmune disease that causes kidney failure. The discovery of anti-brush border antibody (ABBA) ...

On Wednesday, Vor Bio Inc. (NASDAQ:VOR) announced that its collaborator, RemeGen Co., Ltd., achieved the primary endpoint in Stage A of a Phase 3 clinical study in China evaluating telitacicept in ...

PIONEER study expands the investigation of atacicept into a broad definition of IgA nephropathy and into multiple autoimmune glomerular diseases, supported by the disease-modifying potential of ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

IgA nephropathy is an autoimmune kidney disease, and complement, a component of the innate immune system, plays a role in the condition's pathogenesis. Investigators have developed and tested a novel ...

IgA Nephropathy (IgAN) is an autoimmune kidney disease. Without treatment, it can cause a variety of complications. Treatment focuses on disease management and slowing disease progression. Also known ...

The central function of the kidneys is to excrete waste products and to maintain water and electrolyte homeostasis in the body. The kidneys also regulate erythropoiesis, blood pressure and bone ...

More than 37 million Americans live with chronic kidney disease, yet most remain unaware of their condition until significant damage has already occurred. The silent nature of kidney disease makes it ...

BRISBANE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative ...